PEspeaks

Jun 25, 2015
For the second time in three years, the Supreme Court of the United States (SCOTUS) has weighed in on key aspects of the 2010 Obamacare law. Tom Norton reports.
Jun 24, 2015
In the white heat of a major brand launch, we can become consumed by the day to day challenges and make mistakes. But some of the worst mistakes can be avoided with a little foresight, writes Ken Begasse.
Jun 23, 2015
William Looney looks at the key predictions from EvaluatePharma's World Preview 2015, launched at last week's BIO International Convention.
Jun 23, 2015
Applied Clinical Trials
Conversely, social media discussions about study requirements and procedures may discourage participation and undermine study integrity, according to experts at last week’s Drug Information Association (DIA) annual meeting in Washington, D.C.
Jun 20, 2015
With Ireland’s signing of a vaccine procurement agreement this month, the EU’s move toward joint action on medicine acquisition is gathering pace, writes Reflector.
Jun 15, 2015
With the talk shifting (again) to a Greek exit from the eurozone, what are the implications for pharma?
Jun 09, 2015
The pharma industry is making progress and going through a frenzy of activity on the strategic, business, M&A and financial fronts, writes Peter Young.
Jun 07, 2015
Drug quality issues have forced the National Institutes of Health to shutter its in-house facility for producing clinical supplies for certain clinical trials. Jill Wechsler reports.
Jun 03, 2015
Michael Christel speaks to Merck & Co. Chief Medical Officer Dr. Michael Rosenblatt about the opportunities and challenges of sharing clinical trial data.
Jun 02, 2015
For the 17 states that set up their own state exchanges under Obamacare, finding ways to manage a couple aspects of the new law are turning 2015 into a “Year of Harsh Realities.” Tom Norton explains why.